Organization: Health Canada
Year: 2025
Month: January
Request Number: A-2024-001196
Request Summary: Adverse Drug Reaction (ADR) for Amphetamine aspartate monohydrate/ amphetamine sulfate/ dextroamphetamine saccharate/ dextroamphetamine sulfate. Report number: 001110987. ADR for Mesalazine. Report number: E2B_07475683. ADRs for C1 Esterase Inhibitor (Human). Report numbers: E2B_07479365, E2B_07482941, E2B_07474142, E2B_07472369. ADRs for GAMMAGARD LIQUID. Report numbers: 001111572, 001111687, 001109538.
Disposition: Disclosed in part
Number of pages: 107